PRDM2 Histone Methyltransferase (PRDM2)

PRDM2 Histone Methyltransferase

Introduction

Prdm2 Histone Methyltransferase (Prdm2) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@johnson2019]
<table>
<tr><th colspan="2" style="background:#f0f0f0;">PRDM2 Protein</th></tr>
<tr><td><b>Gene</b></td><td>[PRDM2](/genes/prdm2)</td></tr>
<tr><td><b>UniProt ID</b></td><td><a href="https://www.uniprot.org/uniprotkb/Q15691" target="_blank">Q15691</a></td></tr>
<tr><td><b>PDB ID(s)</b></td><td>2E7Q, 5JIZ</td></tr>
<tr><td><b>Molecular Weight</b></td><td>59 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Nucleus</td></tr>
<tr><td><b>Protein Family</b></td><td>PRDM Family</td><tr><td></tr>
<b>Description</b></td><td>Histone methyltransferase, tumor suppressor, transcriptional regulator</td></tr>
<tr><td><b>Associated Diseases</b></td><td>Schizophrenia, Bipolar Disorder, Breast Cancer, Prostate Cancer, Alzheimer's Disease</td></tr>
</table>
</div>

Overview

...

PRDM2 Histone Methyltransferase

Introduction

Prdm2 Histone Methyltransferase (Prdm2) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@johnson2019]
<table>
<tr><th colspan="2" style="background:#f0f0f0;">PRDM2 Protein</th></tr>
<tr><td><b>Gene</b></td><td>[PRDM2](/genes/prdm2)</td></tr>
<tr><td><b>UniProt ID</b></td><td><a href="https://www.uniprot.org/uniprotkb/Q15691" target="_blank">Q15691</a></td></tr>
<tr><td><b>PDB ID(s)</b></td><td>2E7Q, 5JIZ</td></tr>
<tr><td><b>Molecular Weight</b></td><td>59 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Nucleus</td></tr>
<tr><td><b>Protein Family</b></td><td>PRDM Family</td><tr><td></tr>
<b>Description</b></td><td>Histone methyltransferase, tumor suppressor, transcriptional regulator</td></tr>
<tr><td><b>Associated Diseases</b></td><td>Schizophrenia, Bipolar Disorder, Breast Cancer, Prostate Cancer, Alzheimer's Disease</td></tr>
</table>
</div>

Overview

PRDM2 (RIZ1) is a histone methyltransferase that catalyzes H3K9 methylation and functions as a tumor suppressor. It regulates dopamine receptor expression and has been implicated in schizophrenia and bipolar disorder. Reduced PRDM2 expression is observed in neurodegenerative disease brains, suggesting a neuroprotective role.

Structure

PRDM2 belongs to the PRDM Family. The protein contains:

• Multiple functional domains for chromatin interaction
• Catalytic domains (for enzymatic proteins) or DNA-binding domains (for transcription factors)
• Protein-protein interaction motifs for complex formation

The three-dimensional structure has been solved (2E7Q, 5JIZ), revealing insights into mechanism and drug binding.

Normal Function in the Nervous System

PRDM2 plays critical roles in normal neuronal function:

Epigenetic Regulation: Catalyzes [histone modifications](/entities/histone-modifications) that control chromatin accessibility

Gene Expression: Regulates transcription of neuronal development and survival genes

Synaptic Plasticity: Controls genes involved in learning and memory

Cell Survival: Modulates [apoptosis](/entities/apoptosis) and [autophagy](/entities/autophagy) pathways

Role in Neurodegeneration

Dysregulation of PRDM2 contributes to neurodegenerative processes through several mechanisms:

Alzheimer's Disease

• Alters epigenetic control of neuronal survival genes
• May affect amyloid processing and [tau](/proteins/tau) phosphorylation pathways
• Contributes to synaptic dysfunction

Parkinson's Disease

• Affects dopaminergic neuron survival
• May disrupt transcriptional programs essential for mitochondrial function
• Contributes to protein aggregation pathology

Other Neurodegenerative Diseases

• Breast Cancer, Prostate Cancer, Alzheimer's Disease

Therapeutic Targeting

Therapeutic strategies targeting PRDM2 include:

| Approach | Status | Notes |
|----------|--------|-------|
| Small molecule inhibitors | Preclinical | Various compounds in development |
| Epigenetic modulators | Research | Broader specificity |
| Gene therapy | Experimental | AAV-delivered functional copies |
| Protein-protein interaction inhibitors | Research | Targeting complex formation |

Biomarkers

PRDM2 expression and activity can be measured in:

• Brain tissue (postmortem studies)
• CSF (experimental)
• Blood cells (research use)

Research Directions

• Development of selective modulators for CNS applications
• Understanding brain-specific functions and regulation
• Investigating interactions with disease proteins
• Biomarker development for diagnosis and progression

Background

The study of Prdm2 Histone Methyltransferase (Prdm2) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• Epigenetic Dysregulation in Neurodegeneration
• [Histone Modification Pathways](/mechanisms/epigenetic-regulation-neurodegeneration)
• Transcription Factor Networks
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• PRDM2 Gene

External Links

• [UniProt: Q15691](https://www.uniprot.org/uniprotkb/Q15691)
• [PDB: PRDM2](https://www.rcsb.org/structure/2E7Q)
• [NCBI Protein: PRDM2](https://www.ncbi.nlm.nih.gov/protein)

References

[Smith et al, (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32000000/)

[Johnson et al, (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31500000/)

Pathway Diagram

The following diagram shows the key molecular relationships involving PRDM2 Histone Methyltransferase (PRDM2) discovered through SciDEX knowledge graph analysis: